DIAGNOS Receives Regulatory Approval from the Costa Rica
BROSSARD, Quebec, Aug. 18, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Pathology Detection Systems. Real-time updates on events, politics, business and more.